Re: "Posterior reversible encephalopathy syndrome following infliximab infusion".
Zamvar
Veena
V
Puntis
John W
JW
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D000069285:Infliximab; D020258:Neurotoxicity Syndromes / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab